AMPH Open Interest
Amphastar Pharmaceuticals Inc (AMPH) had 443 open option contracts as of Nov 20, 2026: 313 calls and 130 puts. Open interest rose 13.0% over the past four weeks. The put/call open interest ratio is 0.42, which signals bullish sentiment.
Open Interest by Strike
Showing results for AMPH, 2027-03-19(m), calls & puts
Open Interest Stats
Showing results for AMPH, 2027-03-19(m), calls & puts
| Call Open Interest Total | 56 |
|---|---|
| Put Open Interest Total | 26 |
| Open Interest Total | 82 |
| Put-Call Open Interest Ratio | 0.46 |
Highest Open Interest Options
Showing results for AMPH, 2027-03-19(m), calls & puts
Open Interest Total by Expiry
Showing results for AMPH, 2027-03-19(m), calls & puts. View all expiries
Open Interest History
Showing daily totals for AMPH, all expirations, calls & puts. View full history
AMPH Open Interest FAQ
What is open interest?
Open interest is the number of option contracts that are open and not yet closed, exercised, or expired. The Options Clearing Corporation calculates it once a day from the previous day's trades, and it is published before the market opens.
How much open interest does AMPH have?
Amphastar Pharmaceuticals had 443 open option contracts as of Nov 20, 2026. Over the past 30 days, open interest averaged 407 contracts.
Is AMPH open interest rising or falling?
Open interest rose 13.0% over the past four weeks. It was 392 contracts on Oct 23, 2026. See the AMPH open interest history for a longer view.
What is the AMPH put/call open interest ratio?
The Amphastar Pharmaceuticals put/call open interest ratio was 0.42 as of Nov 20, 2026. Four weeks earlier it was 0.40.
What is Amphastar Pharmaceuticals Inc?
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products.